Opus Genetics is trading at $3.70, with a -5.85% change after hours; no verified company-specific catalyst was found for the decline.
- On November 3, 2026, the company announced a November 10 conference fireside chat, not a major business or regulatory development.
- The S&P 500 and Nasdaq rose during the session, so broad-market weakness does not clearly explain the drop. Available evidence does not establish a cause.